SCHEMBL6561

SCHEMBL6561

Cc1noc(-c2ccc(Br)cc2)c1C(C=O)Sc1ccccc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPAR1 Q92633 3/20 0.34
LPAR3 Q9UBY5 1/20 0.34
NR1H4 Q96RI1 1/20 0.34
GAA P10253 1/20 0.34
NR1I2 O75469 1/20 0.33
ABCC3 O15438 1/20 0.32
ABCC4 O15439 1/20 0.32
ABCB11 O95342 1/20 0.32
CYP2C8 P10632 1/20 0.32
CYP2C9 P11712 1/20 0.32
ABCB4 P21439 1/20 0.32
ABCC2 Q92887 1/20 0.32
SLCO1B3 Q9NPD5 1/20 0.32
SLCO1B1 Q9Y6L6 1/20 0.32
ALDH1A1 P00352 4/20 0.32
EDNRB P24530 3/20 0.32
EDNRA P25101 3/20 0.32
MMP1 P03956 1/20 0.32
MMP9 P14780 1/20 0.32
MAPT P10636 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6652 0.85 MEN1 (0.38) EDNRBEDNRASMN1; SMN2NPC1RAB9A
SCHEMBL1933 0.84 EPHX1 (0.34) LPAR1LPAR3NR1H4GAAMAPT
SCHEMBL11409 0.81 TP53 (0.31) CYP2C9EDNRBEDNRAMAPTTDP1
SCHEMBL7387 0.80 NR1I2 (0.35) LPAR1LPAR3NR1H4GAANR1I2
SCHEMBL7689 0.78 CYP1A2 (0.31) CYP2C9TDP1
SCHEMBL1448 0.78 BRD4 (0.35) LPAR1LPAR3CYP2C9ALDH1A1EDNRB
SCHEMBL7386 0.75 SMN1; SMN2 (0.38) LPAR1LPAR3NR1H4GAANR1I2
SCHEMBL2612 0.74 LPAR1 (0.46) LPAR1LPAR3NR1H4GAAABCC3
SCHEMBL1625 0.74 AR (0.37) LPAR1LPAR3NR1H4GAAABCC3
SCHEMBL1464 0.74 GAA (0.38) LPAR1LPAR3NR1H4GAAABCC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2483252-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS Amira Pharmaceuticals, Inc. (US) 2012-08-08 EP disclosed
WO-2011041694-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-04-07 WO disclosed